Skip to content

ScienceIndependently confirmed2 publishers2 min readPublished

Columbia team finds bacterial antiviral enzyme that adds repeat DNA the way telomerase does

Columbia researchers report DRT10, a bacterial antiviral system whose reverse transcriptase writes repeat DNA by a route that parallels human telomerase. The Nature abstract reports bacterial biochemistry, structures and phylogenetics, and Sternberg calls the editing and telomere-repair uses early days.

The Scientist · Science desk

How we use AISend a correction

Photograph accompanying Columbia team finds bacterial antiviral enzyme that adds repeat DNA the way telomerase does
Photo: columbia.edu

What happened

  • Stephen Tang, a graduate student in Samuel Sternberg's lab, found DRT10 in the "Unknown Group", a set of dozens of bacterial reverse transcriptases whose functions were unknown.
  • DRT10 pairs with a noncoding RNA to make long tandem-repeat DNA in a synthesis the protein primes itself.
  • Cryo-EM structures show two reverse transcriptase monomers bound on opposite sides of a pseudo-symmetric RNA, a 2:1 layout the authors call unanticipated.
  • Phylogenetic analyses put telomerase in a single clade with the DRT family, which the authors say suggests a common origin for their DNA polymerization activities.
  • Sternberg's lab hopes to test whether DRT10 could be adapted to treat telomeropathies, diseases caused by defects in telomere maintenance.

Why it matters

  • constraint The abstract describes cryo-EM, biochemistry and phylogenetics and does not mention human cells. Telomeropathy treatment and genome editing with DRT10 are hypotheses until someone shows repeat addition in eukaryotic cells.
  • contradiction Phys.org leads with a gene editor that slows aging and improves cancer therapies. Sternberg's own aim is narrower, and he opens it with "It's early days, but we're excited by the possibility of turning a bacterial defense enzyme into a tool to rebuild protective DNA at chromosome ends."
  • precedent DRT10 joins DRT2, DRT3 and DRT9 as a system adding RNA-templated DNA repeats by different architectures. With dozens of Unknown Group enzymes still uncharacterized, we'd expect more repeat-writing defense systems to turn up.

The parallel to telomerase is specific. In DRT10, reverse transcription is templated by a defined region of the noncoding RNA, and the authors report that its characteristic sequence pattern and its template boundary elements are both conserved and essential for adding DNA repeats [4]. Of the two reverse transcriptase monomers on the RNA, each copies the template on its own side. Only one makes the long repetitive product, and the length of its template is set by the distance between two flanking stem-loop anchors [10]. The abstract calls this iterative, boundary-delimited synthesis and says it directly parallels how eukaryotic telomerase adds telomeric repeats [5].

Telomerase builds the DNA caps that protect the ends of linear chromosomes in humans and most other eukaryotes [12]. Tang noticed the resemblance while working out how the DRT10 enzyme operates [3].

The sequence tree is the abstract's evidence for shared ancestry, and it supports a narrower statement than the Phys.org account makes. That account calls the telomerase relationship "likely and surprising" and says the work sheds light on an ancient event that may have helped set the stage for higher organisms [8]. The abstract says "suggesting" and confines the common origin to the DNA polymerization activities [2]. In our view, a shared ancestor for the polymerase does not date when chromosome-end protection arose.

On tools, Sternberg, the study's senior author, was direct about what the system offers. "Instead of cutting DNA like CRISPR, or swapping one letter of genetic code like base editors, this system uses RNA as a template to write new sequences of DNA. That gives us a different starting point for building tools to engineer cells," he said [15].

The aim for this enzyme group, as the account puts it, is gene-editing tools that write therapeutic sequences into the genome [14]. DRT10 as described adds tandem repeats from its own RNA template [1]. The thing this doesn't tell you is whether that template can be swapped for a sequence of someone's choosing.

The case for slowing aging runs through senescence. Telomere shortening makes aging cells senesce, and the build-up of senescent cells is linked to several age-related diseases. The account says this raises "the possibility that restoring telomeres could help preserve healthy cell function" [13].

What to watch

  • Whether the Sternberg lab shows DRT10, or a redesigned version, adding DNA repeats in eukaryotic cells, which is the test the telomeropathy idea depends on.
  • Whether anyone shows the RNA template can be swapped so the enzyme writes a non-repeat sequence, which a general editing tool would need.
  • Independent re-analysis of the tree that places telomerase with the DRT family, using the alignment and structure data the paper releases.

Clarity's read

What the record supports and how the coverage leans. The claims behind it follow.

Reality

Evidence68
Adoption
Insufficient
Hype gap+25
Incentives
Insufficient
Confidence70
Why these scores

Claim ledger

Ranked by verification strength, evidence, and original report placement.

  1. [1]

    DRT10 associates with a noncoding RNA to catalyze processive, protein-primed synthesis of tandem-repeat DNA.

    ReportedSupportedSource: Nature abstract, Tang et al.2 sources— create a free account to open themView cited source
  2. [2]

    Phylogenetic analyses of reverse transcriptases across domains of life place telomerase in a monophyletic clade with the DRT family, suggesting a common origin for their DNA polymerization activities.

    ReportedSupportedSource: Nature abstract, Tang et al.2 sources— create a free account to open themView cited source
  3. [3]

    While digging into how the reverse transcriptase operates, Tang realized the enzyme works much like telomerase.

    ReportedSupportedSource: Phys.org account of the Columbia work2 sources— create a free account to open themView cited source

Sources

2 independent publishers whose own reporting we read for this story.

  1. nature.com

    1 article · October 11, 2026

    Antiviral immunity via telomerase-like reverse transcription in bacteria
  2. phys.org

    1 article · October 12, 2026

    Bacterial antiviral defense suggests ancient link to human chromosome protection

Share your take

Let Clarity write the post for you.

Signed-in readers get a short post drafted on this story in the register they choose — narrative, analytical, or a direct position — editable to the last word before it goes anywhere. The share buttons at the top of this story work without an account.

Topics and entities

Follow any of these and your For You feed starts watching them — no settings page required.

Topics

  • Genome editingFollow
  • Telomerase and telomeresFollow
  • Bacterial antiviral defenseFollow
  • Reverse transcriptase evolutionFollow

Entities

Loading related stories